Table 1 Baseline characteristics of the study population

Age (yr)

62 (50, 71)

61 (52, 69)

63 (50, 71)

62 (50, 72)

0.968

Sex (male, %)

125 (61.3%)

24 (40.0%)

71 (64.5%)

30 (55.6%)

0.531

APACHEII

21 (16, 27)

21 (17, 26)

20 (15, 25)

21 (17, 26)

0.208

SOFA

11 (9, 14)

10 (8, 12)

11 (9, 13)

13 (10, 16)

0.019^b

 Shock

91 (44.6%)

9 (22.5%)

51 (46.4%)

31 (57.4%)

0.003^b

 Respiratory failure

33 (16.2%)

7 (17.5%)

19 (17.3%)

7 (13.0%)

0.756

 HTN

83 (40.7%)

15 (37.5%)

44 (39.1%)

24 (44.4%)

0.777

 DM

68 (23.3%)

13 (32.5%)

39 (35.5%)

16 (29.6%)

0.753

 CAD

47 (23.0%)

9 (22.5%)

29 (26.4%)

9 (16.7%)

0.381

 CKD

8 (3.9%)

1 (2.5%)

5 (4.5%)

2 (3.7%)

0.846

 COPD

9 (4.4%)

1 (2.5%)

7 (6.4%)

1 (1.9%)

0.336

 MV (n, %)

159 (77.9%)

18 (45.0%)

92 (83.6%)

49 (90.7%)

< 0.001^{b b, C}

^*Fluid administration (ml)

3430 (2388, 4236)

2938 (2301, 4361)

3430 (2535, 4147) 707)

3561 (2213, 4279)

0.608

Vasopressor (n, %)

136 (66.7%)

19 (47.5%)

72 (65.5%)

45 (83.3%)

0.001^b

Scr (μmol/L)

93 (67, 152)

94 (65, 150)

87 (68, 137)

94 (64, 178)

0.396

CVVH (n, %)

37 (18.1%)

6 (15.0%)

18 (16.4%)

13 (24.1%)

0.411

ICU stay (day)

7 (4, 12)

7 (5, 15)

6 (4, 15)

6 (3, 10)

0.362

ICU mortality (n, %)

35 (17.2%)

2 (5.0%)

20 (18.2%)

13 (24.1%)

0.048^b